Rating History for Protagonist Therapeutics (PTGX) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/10/2026 | Richard Law | Upgrade | Buy (Neutral) |
186.00 (110.00) |
146.18 (146.49) |
0.21% | Details |
 |
|||||||
|
|||||||
